Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Example Input: Since 2000, 34 of Iowa's 118 community hospitals have closed their birthing units, according to the Iowa Department of Public Health. There have been two so far this year, down from eight closures last year the most in a single year. Most of those closures have happened at smaller facilities than the 49-bed Marshalltown hospital. Iowa's aging population is a key reason for these closures, Dr. Stephen Hunter, vice chairman of obstetrics at the University of Iowa Hospital & Clinics in Iowa City, told Iowa Public Radio . "Some rural counties have lost as many as 40 percent of their population in the last three decades," Hunter said. "That's a lot of people gone, unfortunately. That leaves a system that's not adequate for those that remain in those counties." Hunter said the state is also facing a severe shortage of OB/GYNs and family practice doctors who practice obstetrics. And, he said, Medicaid reimbursements are so low for obstetrics that hospitals can't support the service. According to figures from the University of Iowa Hospitals & Clinics, Medicaid reimbursed it about one-third of what commercial insurance plans did for services such as ultrasounds and deliveries last year. Competition from bigger hospitals in bigger cities presents a business challenge, too. "There simply aren't enough women choosing to deliver locally," UnityPoint Health President Jenni Friedly said. "This is a problem that has been going on for a long time. . There are enough women becoming pregnant, but they are going elsewhere to deliver. It's clear OB/GYN patients are already selecting Ames and Des Moines for their care." Stephanie Trusty, a nurse who tracks birthing trends for the state, told the Marshalltown Times-Republican that "some of these birthing units are beautiful. They're like a four-star hotel." But does the loss of birthing units at the smaller hospitals and consolidation of birthing services affect health outcomes? A 2017 University of Minnesota study said the loss of labor and delivery units in smaller, more remote counties is linked with a decrease in prenatal care and increase in out-of-hospital and preterm births. The Iowa Public Health Department and the University of Iowa are keeping watch for any such problems, but so far have not seen any sizable incidence, Trusty said. Hansen Family Hospital CEO Doug Morse in Iowa Falls told Iowa Public Radio that hospital officials decided labor and delivery care were too expensive to continue in the aging, rural community with a declining birth rate. After three months of public meetings, Morse said, hospital officials opted to use half the money they would save to turn the unit into a mental health program for seniors. "It really did become fairly clear that people recognize that this wasn't necessarily ... delivering babies isn't necessarily a service that matches an elderly population," he said. The closing of the birth unit at the Iowa Falls hospital forced Jessica Sheridan to change her plans to have her baby born there, just five minutes from her home. She established relationships with doctors in Ames, an hour away, where her daughter was delivered in mid-December. "We were lucky. It was nice weather," Sheridan said.
Example Output: Costs forcing some hospitals to stop delivering babies.

Example Input: "In a show of Republican muscle, Florida lawmakers passed several bills relating to abortion during this year's legislative session. One proposal awaiting the signature of Gov. Rick Scott requires young women who want a judge to waive the parental-notification requirement to obtain the waiver in a circuit court closer to their home rather than a wider-reaching appeals court. Opponents insist HB 1247 violates the privacy of young women who live in small communities and know most people in their area, including people who work at the courthouse. But supporters say it prevents teens from crossing the state to find a sympathetic judge in order to get an abortion without their parents' knowledge. Sen. Steve Oelrich, a Republican from Gainesville and cosponsor of the Senate version, had an interesting take during a May 5, 2011, debate on the Senate floor. ""You can't give a child an aspirin in school without permission,"" he said. ""You can't do any kind of medication, but we can secretly take the child off and have an abortion. We should support it (HB 1247) with all our hearts and souls if parental responsibility means anything to us."" Oelrich's claim left us wondering: Is it really that hard for students to get over-the-counter medication at school? We should explain that we're not ruling on Oelrich's statement that young women can ""secretly"" have abortions. We already know this is legal in certain cases under Florida law. Implementation of HB 1247 would limit which courts can make the decisions for women who seek waivers of the parental notification law, not strip their ability to have secret procedures. Florida law The Florida Statutes have straightforward directions for handling prescription medication at school. The law requires a student's parent to submit a written statement with the medicine that permits a trained school official to administer a dose. The note must also explain why the medicine must be taken during the school day. The prescription medicine must be administered at school by a qualified official and then be counted, stored in the original container, and kept in a secured place. Beyond that, the law does not address the use of over-the-counter medication. The statutes leave that decision up to local school districts. We set out to check each one to learn if Oelrich's claim is . We tracked down policies for 62 of 67 counties. Most were available online. It took time to be sure, but Oelrich is right. Every district requires parental consent for non-prescription medication, sometimes in writing and sometimes by phone. Notifying a parent is the minimum step for many other districts, including Charlotte, Baker and Miami-Dade. These districts require a physician's note, too. ""We don't administer anything in Charlotte County without doctors' orders,"" said Gail Buck, supervisor of the county's school health services. ""No cough drops, no Tylenol."" Aspirin warnings There's another part to this claim: Oelrich specifically invoked aspirin on the Senate floor. Some of the school nurses we interviewed practically shuddered at the word. The reason? Aspirin use among children is linked to the development of Reye's Syndrome, a lethal disease that sets in after a viral infection and affects all organs of the body, according to the National Reye's Syndrome Foundation. The National Institutes of Health and the Centers for Disease Control and Prevention are among entities that recommend not using aspirin, or combination medicine containing aspirin, for children under 19 during fever-causing illnesses. ""We stay away from all aspirin products and stuff,"" said Catherine Reckenwald, student health specialist for Citrus County Schools. ""You don't know if a child has an allergy, so you need to have very specific instructions for each student."" Reckenwald said Tylenol is more appropriate for children, but she does not keep a supply in her clinic. This is standard practiceat most of the school health centers we contacted. ""We do not have what is called 'standing orders,' "" said Janice Karst, St. Lucie County School Board director of communications. In case you were wondering, students are allowed to self-administer epinephrine auto-injectors, metered dose inhalers, pancreatic enzyme supplements and diabetic supplies if they have a doctor's note and parental consent. Our ruling The thrust of Oelrich's point is correct: You can't give a child an aspirin in school without permission. To administer any non-prescription medication, school officials must have approval from the parent. And in some cases, the schools also need a note from a doctor -- even for cough drops. While Oelrich is right about the permission part, he specifically mentioned aspirin so we should add that giving aspirin to children is considered risky because of the medicine's connection to a deadly disease. But that wasn't exactly Oelrich's point in a debate over abortion and a minor's right to privacy."
Example Output: You can't give a child an aspirin in school without permission. You can't do any kind of medication, but we can secretly take the child off and have an abortion.

Example Input: The news release does not bring up costs, but we'll rate this Not Applicable since the release is clear that this is early-stage work that is not yet ready for use in humans. Some mention of costs would have been valuable nonetheless. Gene therapy is known to be extremely costly, and when a disease is rare, as this is, that raises questions about what company would find it profitable to pursue the potential treatment. The University of Utah provides some excellent background on the "commercial viability" of gene therapy. The release squeaks by on this. There are no numbers used to quantify, but this excerpt at least touches on the method of measurement and the three-year follow up. "The treated dogs had expressed levels of clotting factor VII that would be therapeutic in humans, with long-term stability. In one dog, the effects persisted nearly three years." The release could have explained whata "therapeutic" expression level of clotting factor actually means. A closer look at the paper reveals that a clinically therapeutic level is greater than or equal to 15% of normal. The release addresses harms in a couple of places, as in this excerpt: "The FVII-deficient dogs tolerated the initial gene therapy infusions very well and have had no adverse side effects over several years of follow up." and in a quote by the lead researcher: "Based on kidney function, liver function, and blood measurements in the dogs, the treatment was safe, and did not elicit unwanted immune responses." But as this study was done in canines, we would have liked a bit more detail on how harms might manifest in human clinical trials. The limited information given in the news release describes the quality of the evidence, particularly the fact that this was an animal study that is not directly applicable to humans. The release notes that the study "sets the stage for clinical trials in humans." The release could have noted thata study with only four (canine) participants is very small. There is no disease mongering. There were no conflicts identified. All the funding sources were listed. The release tells us that this rare clotting disorder is currently treated by infusions of clotting factors. The release could have done a better job of explaining how difficult that therapy is for patients. Is the disorder regulated well by that method? We aren't given any information or what those costs are vs. what a one-time gene therapy might cost. The release makes clear that this treatment will not be available until human clinical trials are conducted. This gene therapy is novel for this particular condition. The news release should also be commended for pointing out that a similar gene therapy approach has been tested by the same researchers for hemophilia. It's admirable that they are not overselling the novelty of this approach by referencing their own previous work in related areas. We were pleased to see proof-of-concept in the headline, because this is a very useful way to immediately alert readers that an idea has been validated, but not a therapy for human patients.
Example Output:
Gene therapy for rare bleeding disorder achieves proof-of-concept